Health Care: Drugs

AstraZeneca PLC (AZN: NYSE)

$52.17 0.09 | 0.17%
05/24/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 27.97B 33.59B 33.27B 32.80B
Cost of Sales 2.88B 3.48B 3.65B 3.69B
Gross Operating Profit 25.10B 30.12B 29.62B 29.12B
Selling, General, and Administrative Expenses 10.16B 11.51B 10.78B 11.63B
Research & Development 5.24B 5.52B 5.32B 4.41B
Operating Income before D & A (EBITDA) 9.70B 13.08B 13.52B 13.08B
Depreciation & Amortization 2.52B 2.55B 2.74B 2.09B
Interest Income 528.00M 552.00M 516.00M 462.00M
Other Income - Net 970.00M 0.00 712.00M 553.00M
Special Income / Charges 0.00 2.26B 0.00 0.00
Total Income Before Interest Expenses (EBIT) 8.68B 13.35B 12.01B 12.00B
Interest Expense 958.00M 980.00M 1.03B 1.20B
Pre-Tax Income 7.72B 12.37B 10.98B 10.81B
Income Taxes 1.39B 2.35B 2.90B 3.26B
Minority Interest 30.00M 33.00M 28.00M 23.00M
Net Income From Continuing Operations 6.33B 0.00 0.00 0.00
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 6.33B 0.00 0.00 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 6.30B 9.98B 8.05B 7.52B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 6.33B -2.26B 0.00 0.00
Preferred Dividends
Net Income Available To Common 6.33B 0.00 0.00 0.00
Basic EPS from Continuing Ops. 4.99 7.33 5.60 5.19
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 4.99 7.33 5.60 5.19
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 4.99 7.33 5.60 5.19
Basic Normalized Net Income/Share 4.99 n.a. n.a. n.a.
EPS fr Continuing Ops. 4.98 7.30 5.57 5.19
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 4.98 7.30 5.57 5.19
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 4.98 7.30 5.57 5.19
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 4.98 n.a. n.a. n.a.
Dividends Paid per Share 2.85 2.70 2.41 2.09

Portfolios with AZN

View All

Latest AZN Headlines from TheStreet

More Financial News for AZN

Press Releases for AZN

See All Press Releases

Partner Headlines for AZN

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter